company

RECCURA THERAPEUTICS AS

7042 TRONDHEIM

Return on Equity
−803,73 %
Current Ratio
1,58
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue937 000
Net Income−17 449 000
Total Assets5 051 000
Total Equity2 171 000
Income (NOK)2022
Revenue937 000
Expenditure18 275 000
Operating Profit−17 338 000
Financial Income277 000
Financial Costs388 000
Financial Balance−111 000
Earnings Before Tax−17 449 000
Tax0
Net Income−17 449 000
Balance (NOK)2022
Total Fixed Assets489 000
Total Current Assets4 562 000
Total Assets5 051 000
Total Retained Equity0
Total Equity2 171 000
Total Long-Term Debt0
Total Current Debt2 880 000
Total Equity and Debt5 051 000
Cash flow (NOK)2022
Sales Income0
Other Income937 000
Revenue937 000
Cost of Goods Sold22 000
Salary Costs1 465 000
Depreciation44 000
Impairment0
Expenditure18 275 000
Operating Profit−17 338 000
Financial Income277 000
Financial Costs388 000
Financial Balance−111 000
Dividends0
Net Income−17 449 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities459 000
Fixtures0
Total Tangible Assets459 000
Total Fiancial Fixed Assets30 000
Total Fixed Assets489 000
Stock0
Total Investments0
Cash, Bank2 384 000
Total Current Assets4 562 000
Total Assets5 051 000
Total Equity2 171 000
Short-Term Group Debt40 000
Total Long-Term Debt0
Creditors2 011 000
Unpaid Taxes107 000
Dividends0
Other Current Debt722 000
Total Current Debt2 880 000
Total Equity and Debt5 051 000
Financial indicators2022
Return on Equity−803,73 %
Debt-to-Equity Ratio0
Operating Profit Margin−1 850,37 %
Current Ratio1,58
Quick Ratio1,58
Equity Ratio0,43
Gross Profit Margin97,65 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English